Janssen (Netherlands)

本机构学者在这里署名、按本站篇数

合作机构同一篇文章里的其他机构

1. Cilag (Switzerland)3
2. Finnish Institute for Health and Welfare芬兰2
3. Janssen (Belgium)比利时2
4. Janssen Research & Development (United States)美国2
5. Aarhus University丹麦1
6. Regione Emilia-Romagna1
7. Agenzia Regionale di Sanità della Toscana意大利1
8. Swansea University英国1

按月发文

逐年被引

最新文献

1. 1
   Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION ProjectDrug Safety20252
2. 2
   Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019Pharmacoepidemiology and Drug Safety20243
3. 3
   Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision makingPharmacoepidemiology and Drug Safety202316
4. 4
   Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databasesPharmacoepidemiology and Drug Safety20224
5. 5
   Development and performance characteristics of novel code‐based algorithms to identify invasive Escherichia coli diseasePharmacoepidemiology and Drug Safety20223
6. 6
   Exposure to Infliximab During Pregnancy: Post-Marketing ExperienceDrug Safety201935

高被引文献

1. 1
   Exposure to Infliximab During Pregnancy: Post-Marketing ExperienceDrug Safety201935
2. 2
   Landscape review of global real‐world data sources for studying medication use in pregnancy and lactation that support regulatory decision makingPharmacoepidemiology and Drug Safety202316
3. 3
   Performance characteristics of code‐based algorithms to identify urinary tract infections in large United States administrative claims databasesPharmacoepidemiology and Drug Safety20224
4. 4
   Pregnancy and Infant Outcomes After Prenatal Exposure to Golimumab in Denmark, Finland, and Sweden 2006–2019Pharmacoepidemiology and Drug Safety20243
5. 5
   Development and performance characteristics of novel code‐based algorithms to identify invasive Escherichia coli diseasePharmacoepidemiology and Drug Safety20223
6. 6
   Identifying Maternal Conditions Leading to Gabapentinoid Prescriptions in Pregnancy Using Electronic Health Records from Six European Countries: A Contribution from the IMI ConcePTION ProjectDrug Safety20252

主要发表期刊